Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, Vosevi, Vemlidy, and Viread for the treatment of liver diseases. It also offers Yescarta, Tecartus, Trodelvy, and Zydelig products for the treatment of hematology, oncology, and cell therapy patients. In addition, the company provides Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; Ranexa, an oral formulation for the treatment of chronic angina; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. Gilead Sciences, Inc. has collaboration agreements with Arcus Biosciences, Inc.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Tango Therapeutics, Inc.; Jounce Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Gadeta B.V.; Bristol-Myers Squibb Company; Dragonfly Therapeutics, Inc.; and Merck & Co, Inc. The company was incorporated in 1987 and is headquartered in Foster City, California.
Gilead Sciences Dividend Announcement
• Gilead Sciences announced a quarterly dividend of $0.77 per ordinary share which will be made payable on 2024-09-27. Ex dividend date: 2024-09-13
• Gilead Sciences annual dividend for 2024 was $2.31
• Gilead Sciences annual dividend for 2023 was $3.00
• Gilead Sciences's trailing twelve-month (TTM) dividend yield is 3.91%
• Gilead Sciences's payout ratio for the trailing twelve months (TTM) is 3862.70%
• Gilead Sciences's dividend growth over the last five years (2018-2023) was 5.64% year
Gilead Sciences Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-09-13 | $0.77 | quarterly | 2024-09-27 |
2024-06-14 | $0.77 | quarterly | 2024-06-27 |
2024-03-14 | $0.77 | quarterly | 2024-03-28 |
2023-12-14 | $0.75 | quarterly | 2023-12-28 |
2023-09-14 | $0.75 | quarterly | 2023-09-28 |
2023-06-14 | $0.75 | quarterly | 2023-06-29 |
2023-03-14 | $0.75 | quarterly | 2023-03-30 |
2022-12-14 | $0.73 | quarterly | 2022-12-29 |
2022-09-14 | $0.73 | quarterly | 2022-09-29 |
2022-06-14 | $0.73 | quarterly | 2022-06-29 |
2022-03-14 | $0.73 | quarterly | 2022-03-30 |
2021-12-14 | $0.71 | quarterly | 2021-12-30 |
2021-09-14 | $0.71 | quarterly | 2021-09-29 |
2021-06-14 | $0.71 | quarterly | 2021-06-29 |
2021-03-12 | $0.71 | quarterly | 2021-03-30 |
2020-12-14 | $0.68 | quarterly | 2020-12-30 |
2020-09-14 | $0.68 | quarterly | 2020-09-29 |
2020-06-11 | $0.68 | quarterly | 2020-06-29 |
2020-03-12 | $0.68 | quarterly | 2020-03-30 |
2019-12-12 | $0.63 | quarterly | 2019-12-30 |
2019-09-12 | $0.63 | quarterly | 2019-09-27 |
2019-06-13 | $0.63 | quarterly | 2019-06-27 |
2019-03-14 | $0.63 | quarterly | 2019-03-28 |
2018-12-13 | $0.57 | quarterly | 2018-12-28 |
2018-09-13 | $0.57 | quarterly | 2018-09-27 |
2018-06-14 | $0.57 | quarterly | 2018-06-28 |
2018-03-15 | $0.57 | quarterly | 2018-03-29 |
2017-12-14 | $0.52 | quarterly | 2017-12-28 |
2017-09-14 | $0.52 | quarterly | 2017-09-28 |
2017-06-14 | $0.52 | quarterly | 2017-06-29 |
2017-03-14 | $0.52 | quarterly | 2017-03-30 |
2016-12-13 | $0.47 | quarterly | 2016-12-29 |
2016-09-14 | $0.47 | quarterly | 2016-09-29 |
2016-06-14 | $0.47 | quarterly | 2016-06-29 |
2016-03-14 | $0.43 | quarterly | 2016-03-30 |
2015-12-14 | $0.43 | quarterly | 2015-12-30 |
2015-09-14 | $0.43 | quarterly | 2015-09-29 |
2015-06-12 | $0.43 | quarterly | 2015-06-29 |
Gilead Sciences Dividend per year
Gilead Sciences Dividend growth
Gilead Sciences Dividend Yield
Gilead Sciences current trailing twelve-month (TTM) dividend yield is 3.91%. Interested in purchasing Gilead Sciences stock? Use our calculator to estimate your expected dividend yield:
Gilead Sciences Financial Ratios
Gilead Sciences Dividend FAQ
Other factors to consider when evaluating Gilead Sciences as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Gilead Sciences stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Gilead Sciences's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Gilead Sciences publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Gilead Sciences distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Gilead Sciences are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Gilead Sciences sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Gilead Sciences distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Gilead Sciences declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Gilead Sciences's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Gilead Sciences's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.